The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Mitochondria‐targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants
Abstract
Friedreich Ataxia (FRDA), the most common inherited ataxia, arises from defective expression of the mitochondrial protein frataxin, which leads to increased mitochondrial oxidative damage. Therefore, antioxidants targeted to mitochondria should be particularly effective at slowing disease progression. To test this hypothesis, we compared the efficacy of mitochondria‐targeted and untargeted antioxidants derived from coenzyme Q 10 and from vitamin E at preventing cell death due to endogenous oxidative stress in cultured fibroblasts from FRDA patients in which glutathione synthesis was blocked. The mitochondria‐targeted antioxidant MitoQ was several hundredfold more potent than the untargeted analog idebenone. The mitochondria‐targeted antioxidant MitoVit E was 350‐fold more potent than the water soluble analog Trolox. This is the first demonstration that mitochondria‐targeted antioxidants prevent cell death that arises in response to endogenous oxidative damage. Targeted antioxidants may have therapeutic potential in FRDA and in other disorders involving mitochondrial oxidative damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In other studies, the EC50 for MitoQ in cultured cells was <0.5 nM, and the protective effect then plateaued over several logs of concentration (Jauslin et al., 2003).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Jauslin et al., 2003
In the citing paper
“There is extensive in vitro evidence that the concentrations of MitoQ used here have no impact on mitochondrial functions, such as ATP production, membrane potential, or ROS production in cells or mitochondria, but do prevent mitochondrial oxidative damage under conditions that lead to oxidative stress (Kelso et al., 2001; Jauslin et al., 2003; Saretzki et al., 2003; Asin-Cayuelaa et al., 2004).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Jauslin et al., 2003
In the citing paper
“Mitochondrially-targeted coenzyme Q (MitoQ) or mitochondrially-targeted vitamin E (MitoVitE) have been shown to target mitochondrial dysfunction282,283.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [283]
In the citing paper
“Mitochondrial-targeted antioxidants protected Friedreich ataxia fibroblasts, in which glutathione synthesis was blocked, from oxidative stress (148)”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [148]
In the citing paper
“In glioma cells, astrocytes, and macrophages, Fpn associates with ceruloplasmin (Cp) (123, 148).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [148]
In the citing paper
“Inability to export iron may explain tissue iron accumulation.”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [148]
In the citing paper
“Adult Cp-knockout mice exhibited accumulation of iron in the cerebellum and brainstem that correlated with the development of deficits in coordination of movement (148).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [148]
In the citing paper
“GPI-anchored Cp was required for export of iron from astrocytes (148) (Table 4).”
From Intracellular iron transport and storage: from molecular mechanisms to health implications (2008) · cites this paper as [148]
Citations
Cites
Friedreich's Ataxia: Autosomal Recessive Disease Caused by an Intronic GAA Triplet Repeat Expansion
Campuzano, V., Montermini, L., Moltò, M. D., Pianese, L., Cossée, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996) · Science · doi:10.1126/science.271.5254.1423 · Cited by 2,786
Selective Targeting of a Redox-active Ubiquinone to Mitochondria within Cells
Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A. J., & Murphy, M. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009093200 · Cited by 1,091
Self-citationRegulation of Mitochondrial Iron Accumulation by Yfh1p, a Putative Homolog of Frataxin
Babcock, M., de Silva, D., Oaks, R., Davis-Kaplan, S., Jiralerspong, S., Montermini, L., Pandolfo, M., & Kaplan, J. (1997) · Science · doi:10.1126/science.276.5319.1709 · Cited by 921
Puccio, H., Simon, D., Cossée, M., Criqui-Filipe, P., Tiziano, F., Melki, J., Hindelang, C., Matyas, R., Rustin, P., & Koenig, M. (2001) · Nature Genetics · doi:10.1038/84818 · Cited by 738
Delivery of bioactive molecules to mitochondria in vivo
Smith, R. A. J., Porteous, C. M., Gane, A. M., & Murphy, M. P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931245100 · Cited by 725
Self-citationSelective targeting of an antioxidant to mitochondria
Smith, R. A. J., Porteous, C. M., Coulter, C. V., & Murphy, M. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00543.x · Cited by 466
Self-citationDrug delivery to mitochondria: the key to mitochondrial medicine
Murphy, M. P., & Smith, R. A. J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00069-1 · Cited by 429
Self-citationSelective targeting of bioactive compounds to mitochondria
Murphy, M. P. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01068-8 · Cited by 366
Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia
Lodi, R., Cooper, J. A. D., Bradley, J. L., Manners, D. N., Styles, P., Taylor, D. J., & Schapira, A. H. V. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11492 · Cited by 352
Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue
Wilson, R. B., & Roof, D. M. (1997) · Nature Genetics · doi:10.1038/ng0897-352 · Cited by 345
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 356
Spivak, A. Y., Nedopekina, D. A., Gubaidullin, R. R., Dubinin, M. V., & Belosludtsev, K. N. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11060470 · Cited by 38
Flavin Adenine Dinucleotide Rescues the Phenotype of Frataxin Deficiency
González‐Cabo, P., Ros, S., & Palau, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008872 · Cited by 39
Schauen, M., Spitkovsky, D., Schubert, J., Fischer, J. H., Hayashi, J., & Wiesner, R. J. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20711 · Cited by 37
Lee, Y.-K., Lau, Y., Ng, K., Lai, W., Ho, S., Tse, H., Siu, C., & Ho, P. W. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.11.101 · Cited by 43
Symptomatic and Disease-Modifying Therapy for the Progressive Ataxias
Perlman, S. (2004) · The Neurologist · doi:10.1097/01.nrl.0000141651.35193.67 · Cited by 38
Covey, M. V., Murphy, M. P., Hobbs, C., Smith, R. A. J., & Oorschot, D. E. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.026 · Cited by 36
Self-citationMao, G., Kraus, G. A., Kim, I., Spurlock, M. E., Bailey, T. B., & Beitz, D. C. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510005830 · Cited by 35
The heart in Friedreich's Ataxia: Basic findings and clinical implications
Payne, R. M. (2011) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2011.02.007 · Cited by 36
Estrogen Protection in Friedreich's Ataxia Skin Fibroblasts
Richardson, T. E., Yang, S., Wen, Y., & Simpkins, J. W. (2011) · Endocrinology · doi:10.1210/en.2011-0184 · Cited by 35
Targeted-mitochondria antioxidants therapeutic implications in inflammatory bowel disease
Matondo, A., & Kim, S. S. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1339196 · Cited by 34
Mitochondrial DNA and Neurodegeneration: Any Role for Dietary Antioxidants?
Bordoni, L., & Gabbianelli, R. (2020) · Antioxidants · doi:10.3390/antiox9080764 · Cited by 32
Novel Gallate Triphenylphosphonium Derivatives with Potent Antichagasic Activity
Cortes, L. A., Castro, L., Pesce, B., Maya, J. D., Ferreira, J., Castro-Castillo, V., Parra, E., Jara, J. A., & López‐Muñoz, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136852 · Cited by 33
Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems
Kuszak, A. J., Espey, M. G., Falk, M. J., Holmbeck, M. A., Manfredi, G., Shadel, G. S., Vernon, H. J., & Zolkipli‐Cunningham, Z. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043644 · Cited by 35
Wang, J., Du, H., Ma, L., Feng, M., Li, L., Zhao, X., & Dai, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020924 · Cited by 31
Pezzini, I., Mattoli, V., & Ciofani, G. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1218461 · Cited by 32
Delivery to mitochondria: a narrower approach for broader therapeutics
Malhi, S. S., & Murthy, R. S. R. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.694864 · Cited by 31
Burelle, Y., Bémeur, C., Rivard, M.-È., Legault, J. T., Boucher, G., Morin, C., Coderre, L., & Rosiers, C. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120767 · Cited by 31
Arciello, M., Gori, M., & Balsano, C. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/971024 · Cited by 31
Pharmacotherapy for Friedreich Ataxia
Tsou, A. Y., Friedman, L. S., Wilson, R. B., & Lynch, D. R. (2009) · CNS Drugs · doi:10.2165/00023210-200923030-00003 · Cited by 30
Stable Isotopes and LC–MS for Monitoring Metabolic Disturbances in Friedreich’s Ataxia Platelets
Worth, A. J., Basu, S. S., Deutsch, E. C., Hwang, W., Snyder, N. W., Lynch, D. R., & Blair, I. A. (2015) · Bioanalysis · doi:10.4155/bio.15.118 · Cited by 30
Les espèces actives de l’oxygène : leyinet leyangde la mitochondrie
Carrière, A., Galinier, A., Fernandez, Y., Carmona, M.-C., Pénicaud, L., & Casteilla, L. (2006) · médecine/sciences · doi:10.1051/medsci/200622147 · Cited by 45
Lew, S. Y., Yow, Y., Lim, L. W., & Wong, K.-H. (2019) · Food Science and Technology · doi:10.1590/fst.09919 · Cited by 29
Sepsis-induced Cardiac Mitochondrial Damage and Potential Therapeutic Interventions in the Elderly
Zang, Q. S. (2014) · Aging and Disease · doi:10.14336/ad.2014.0500137 · Cited by 28
Sang, W., Chen, S., Lin, L., Wang, N., Kong, X., & Ye, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.973108 · Cited by 27
Mitochondria as Potential Targets in Antidiabetic Therapy
Moreira, P. I., & Oliveira, C. R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_14 · Cited by 27
Sinha, R. K., & Eudes, F. (2015) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-015-0763-x · Cited by 26
Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders
Kim, H. K., & Han, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-55330-6_32 · Cited by 27
Mitochondrial Antioxidants Alleviate Oxidative and Nitrosative Stress in a Cellular Model of Sepsis
Apostolova, N., Garcia-Bou, R., Hernández‐Mijares, A., Herance, J. R., Rocha, M., & Víctor, V. M. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0528-0 · Cited by 27
Strategies to target bioactive molecules to subcellular compartments. Focus on natural compounds
Biasutto, L., Mattarei, A., Spina, M. L., Azzolini, M., Parrasia, S., Szabó, I., & Zoratti, M. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.07.060 · Cited by 28
Current and emerging treatment options in the management of Friedreich ataxia
Mancuso, M. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s6916 · Cited by 27
Prevention of Noise-Induced Hearing Loss: Potential Therapeutic Agents
Prell, C. G. L., & Bao, J. (2011) · Springer handbook of auditory research · doi:10.1007/978-1-4419-9523-0_13 · Cited by 28
Lokhmatikov, A. V., Voskoboynikova, N. E., Cherepanov, D. A., Skulachev, M. V., Steinhoff, H., Skulachev, V. P., & Mulkidjanian, A. Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8679469 · Cited by 26
Ren, Z., Yang, N., Ji, C., Zheng, J., Wang, T., Liu, Y., & Zuo, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.030 · Cited by 25
Lee, D., Jo, M. G., Kim, S. Y., Chung, C. G., & Lee, S. B. (2020) · Antioxidants · doi:10.3390/antiox9111056 · Cited by 24
Mitoquinone mesylate (MitoQ) prevents sepsis-induced diaphragm dysfunction
Supinski, G. S., Schroder, E. A., Wang, L., Morris, A. J., & Callahan, L. A. (2021) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01053.2020 · Cited by 25
Rodríguez, L. R., Lapeña-Luzón, T., Calap-Quintana, P., Moltó, M. D., González‐Cabo, P., & Navarro, J. A. (2020) · Antioxidants · doi:10.3390/antiox9080664 · Cited by 24
Cardiac Response to Oxidative Stress Induced by Mitochondrial Dysfunction
Kim, H. K., Nilius, B., Kim, N., Ko, K. S., Rhee, B. D., & Han, J. (2016) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2015_5004 · Cited by 26
Víctor, V. M., McCreath, K. J., & Rocha, M. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106775244136 · Cited by 24
Khan, S., Bano, N., Ahamad, S., John, U., Dar, N. J., & Bhat, S. A. (2024) · Aging and Disease · doi:10.14336/ad.2024.0125-1 · Cited by 27
Kaur, S., Sehrawat, A., Mastana, S. S., Kandimalla, R. J. L., Sharma, P. K., Bhatti, G. K., & Bhatti, J. S. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121995 · Cited by 23
Mitochondria: new drug targets for oxidative stress-induced diseases
Anders, M. W., Robotham, J. L., & Sheu, S. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.1.71 · Cited by 23
Maiti, A. K., Spoorthi, B. C., Saha, N. C., & Panigrahi, A. K. (2018) · Biogerontology · doi:10.1007/s10522-018-9756-6 · Cited by 24
Neonatal rat hypoxia–ischemia: Effect of the anti‐oxidant mitoquinol, and S‐PBN
Hobbs, C., Murphy, M. P., Smith, R. A. J., & Oorschot, D. E. (2008) · Pediatrics International · doi:10.1111/j.1442-200x.2008.02705.x · Cited by 23
Self-citationEmerging antioxidant therapies in Friedreich’s ataxia
Edzeamey, F. J., Ramchunder, Z., Pourzand, C., & Virmouni, S. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1359618 · Cited by 23
Reelfs, O., Abbate, V., Hider, R. C., & Pourzand, C. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.03.041 · Cited by 22
Aging and Oxidative Stress Response in the CNS
Calabrese, V., Butterfield, D. A., & Stella, A. M. G. (2008) · Springer eBooks · doi:10.1007/978-0-387-32671-9_6 · Cited by 23
The emerging significance of mitochondrial targeted strategies in NAFLD treatment
Zhang, T., Nie, Y., & Wang, J. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121943 · Cited by 21
Payne, R. M., Pride, P. M., & Babbey, C. M. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9943-6 · Cited by 23
Martinelli, C., Battaglini, M., Pucci, C., Gioi, S., Caracci, C., Macaluso, G., Doccini, S., Santorelli, F. M., & Ciofani, G. (2020) · ACS Omega · doi:10.1021/acsomega.0c01282 · Cited by 22
Choi, W. S., Mitsumoto, A., & Kochevar, I. E. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00611.x · Cited by 20
Protective effects of SS31 on t-BHP induced oxidative damage in 661W cells
MA, W., Zhu, X., Ding, X., Li, T., Hu, Y., Hu, X., YUAN, L., Lei, L., Hu, A., Luo, Y., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4055 · Cited by 19
Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?
Pilotto, F., Bondio, A. D., & Puccio, H. M. (2024) · Cells · doi:10.3390/cells13040319 · Cited by 25
Evaluation of Mitoquinone for Protecting Against Amikacin-Induced Ototoxicity in Guinea Pigs
Dirain, C. O., Ng, M. R. A. V., Milne‐Davies, B. A., Joseph, J., & Antonelli, P. J. (2017) · Otology & Neurotology · doi:10.1097/mao.0000000000001638 · Cited by 18
Diabetes Mellitus and Myocardial Mitochondrial Dysfunction
König, A., Bode, C., & Bugger, H. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.001 · Cited by 18
Friedreich Ataxia: An Update on Animal Models, Frataxin Function and Therapies
González‐Cabo, P., Llorens, J. V., Palau, F., & Moltó, M. D. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-2813-6_17 · Cited by 19
Chen, W., Zhang, D.-W., Gong, W., Lin, Y., & Ning, G. (2013) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2013.03.088 · Cited by 18
Clinical trial design for Friedreich ataxia - Where are we now and what do we need?
Rummey, C., Kichula, E. A., & Lynch, D. R. (2018) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2018.1449638 · Cited by 17
Investigating mitochondrial radical production using targeted probes
Murphy, M. P. (2004) · Biochemical Society Transactions · doi:10.1042/bst0321011 · Cited by 18
Mitochondrial Chronic Progressive External Ophthalmoplegia
Ali, A., Esmaeil, A., & Behbehani, R. S. (2024) · Brain Sciences · doi:10.3390/brainsci14020135 · Cited by 17
Santos, E. L. W., Dias, B. H. M., de Andrade, A. C. R., Pascoal, A. M. H., Filho, F. E. D. V., Medeiros, F. D. C., & Guimarães, S. B. (2013) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502013000800005 · Cited by 17
Frataxin mRNA Isoforms in FRDA Patients and Normal Subjects: Effect of Tocotrienol Supplementation
Abruzzo, P. M., Marini, M., Bolotta, A., Malisardi, G., Manfredini, S., Ghezzo, A., Pini, A., Tasco, G., & Casadio, R. (2013) · BioMed Research International · doi:10.1155/2013/276808 · Cited by 17
Chen, L., Chen, S., Yang, X., & Min, J. (2023) · Journal of Neuroscience Research · doi:10.1002/jnr.25194 · Cited by 17
Targeting the gene in Friedreich ataxia
Hebert, M. D. (2008) · Biochimie · doi:10.1016/j.biochi.2007.12.005 · Cited by 16
Schaffroth, C., Bogacz, M., Dirdjaja, N., Nißen, A., & Krauth‐Siegel, R. L. (2015) · Molecular Microbiology · doi:10.1111/mmi.13223 · Cited by 16
Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers
Li, Y., Fawcett, J. P., Zhang, H., & Tucker, I. G. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.4.0004 · Cited by 16
Toscano‐Márquez, B., Leung, T. C. S., Hui, J., Charron, F. M., McKinney, R. A., & Watt, A. J. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106157 · Cited by 15
Tao, Z., Huo, J., Hao, X., & Liang, J. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1663136 · Cited by 15
Garcia-Bou, R., Rocha, M., Apostolova, N., Herance, J. R., Hernández‐Mijares, A., & Víctor, V. M. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.02.013 · Cited by 14
Shahid, M., Li, S., Seldin, D. C., Lu, B., Ustyugova, I. V., Chen, X., Zapol, W. M., & Wu, M. X. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.154880 · Cited by 14
In Vitro Antioxidant Activity of Idebenone Derivative-Loaded Solid Lipid Nanoparticles
Montenegro, L., Modica, M. N., Salerno, L., Panico, A. M., Crascì, L., Puglisi, G., & Romeo, G. (2017) · Molecules · doi:10.3390/molecules22060887 · Cited by 14
Banerjee, P., Saha, I., Sarkar, D., & Maiti, A. K. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00501-x · Cited by 13
Advances in Human Mitochondria-Based Therapies
Zhong, G., Venkatesan, J. K., Madry, H., & Cucchiarini, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010608 · Cited by 13
Tiberi, J., Segatto, M., Fiorenza, M. T., & Rosa, P. L. (2023) · Biomedicines · doi:10.3390/biomedicines11051293 · Cited by 12
Nemtsova, Y., Steinert, B. L., & Wharton, K. A. (2023) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2023.103834 · Cited by 12
Wipf, P., Polyzos, A. A., & McMurray, C. T. (2021) · Journal of Huntington s Disease · doi:10.3233/jhd-210510 · Cited by 12
Dietary antioxidants provide differential subcellular protection in epithelial cells
Jarrett, S. G., Cuenco, J., & Boulton, M. E. (2006) · Redox Report · doi:10.1179/135100006x116646 · Cited by 12
Genetic and molecular aspects of sport performance
Bouchard, C., & Hoffman, E. P. (2011) · Medical Entomology and Zoology · Cited by 12
AbuEid, M., Keyes, R. F., McAllister, D. M., Peterson, F. C., Kadamberi, I. P., Sprague, D. J., Chaluvally–Raghavan, P., Smith, B. C., & Dwinell, M. B. (2022) · iScience · doi:10.1016/j.isci.2022.105670 · Cited by 12
Neuroprotection with non-feminizing estrogen analogues: An overlooked possible therapeutic strategy
Simpkins, J. W., Richardson, T. E., Yi, K. D., Perez, E., & Covey, D. F. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.03.013 · Cited by 11
R- and S-Equol have equivalent cytoprotective effects in Friedreich’s Ataxia
Richardson, T. E., & Simpkins, J. W. (2012) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-13-12 · Cited by 11
Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders
Rahman, M. M., Tumpa, M. A. A., Rahaman, M. S., Islam, F., Sutradhar, P. R., Ahmed, M., Alghamdi, B. S. A., Hafeez, A., Alexiou, A. T., Perveen, A., et al. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230316150559 · Cited by 11
Jadidian, A., Antonelli, P. J., & Ojano-Dirain, C. P. (2014) · Otology & Neurotology · doi:10.1097/mao.0000000000000517 · Cited by 10
Lysosomal Ca2+ as a mediator of palmitate-induced lipotoxicity
Oh, S. J., Hwang, Y., Hur, K. Y., & Lee, M. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01379-0 · Cited by 12
Marcuzzi, A., Piscianz, E., Loganes, C., Brumatti, L. V., Knowles, A., Bilel, S., Tommasini, A., Bortul, R., & Zweyer, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010047 · Cited by 11
Friedreich’s Ataxia: A Neuronal Point of View on the Oxidative Stress Hypothesis
Carletti, B., & Piemonte, F. (2014) · Antioxidants · doi:10.3390/antiox3030592 · Cited by 10
Mitochondrial DNA Mutations and Ageing
Whitehall, J. C., Smith, A. L. M., & Greaves, L. C. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-21410-3_4 · Cited by 9
Mitochondrial targeted therapies in MAFLD
Lai, S., Tang, D., & Feng, J. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151498 · Cited by 10
Management of systemic risk factors for chronic tendinopathy
Kabore, C., Salier, Q., Geerts, P., & Kaux, J. (2021) · Science & Sports · doi:10.1016/j.scispo.2020.12.003 · Cited by 8
Nanocarriers for Cytosolic Drug and Gene Delivery in Cancer Therapy
Palakurthi, S., Venkata, K., & Kumar, A. (2011) · InTech eBooks · doi:10.5772/12918 · Cited by 8
Treatment and management issues in ataxic diseases
Perlman, S. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-51892-7.00046-2 · Cited by 8
Nguyen, S. T., Otoi, T., Namula, Z., Widodo, O. S., Tharasanit, T., Chatdarong, K., Nakayama, Y., Nagahara, M., Nakai, A., Hirata, M., et al. (2025) · Animals · doi:10.3390/ani15172497 · Cited by 6
Mitochondria-Targeted Antioxidants
Smith, R. A. J., Hartley, R. C., & Murphy, M. P. (2012) · Oxidative stress and disease · doi:10.1201/b12308-8 · Cited by 9
Self-citationWallace, D. C., Lott, M. T., & Procaccio, V. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00013-6 · Cited by 8
Targeted Drug Delivery to the Mitochondria
Agrawal, U., Sharma, R. K., & Vyas, S. P. (2014) · Advances in delivery science and technology · doi:10.1007/978-3-319-11355-5_7 · Cited by 7
Mitophagy could fight Parkinson’s disease through antioxidant action
Rita, A. D., & Strappazzon, F. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0095 · Cited by 7
5.3 Mitochondrial Production of Oxidants and Their Role in the Regulation of Cellular Processes
Brookes, P. S. (2007) · Springer eBooks · doi:10.1007/978-0-387-30411-3_19 · Cited by 7
Oxidative Stress and Antioxidant Therapies in Friedreich’s Ataxia
Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., Cárcamo-Fonfría, A., Martín-Gómez, M. Á., & Agúndez, J. A. G. (2025) · Cells · doi:10.3390/cells14181406 · Cited by 6
Ren, J., Hua, Y., Liao, Z., Wen, X., & Wang, Q. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.10.029 · Cited by 6
Mitochondrial targeting of potent nanoparticulated drugs in combating diseases
Mandal, A. K. (2022) · Journal of Biomaterials Applications · doi:10.1177/08853282221111656 · Cited by 6
Programmed cell death as a target to interrupt the aging program
Severin, F. F., & Skulachev, V. P. (2011) · Advances in Gerontology · doi:10.1134/s2079057011010139 · Cited by 6
Metadata
- Authors
- Jauslin, M. L., Meier, T., Smith, R. A. J., & Murphy, P. M.
- Affiliations
- Geotech Co., Ltd. (Japan) (JP)
- University of Otago (NZ)
- MRC-Dunn Human Nutrition Unit Cambridge CB2 2XY United Kingdom
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-08-15
- Volume
- 17
- Issue
- 13
- Pages
- 1-10
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2154919554
- Cited by
- 358
- References
- 21
- Citations by year
- 2026: 2 · 2025: 10 · 2024: 8 · 2023: 14 · 2022: 11 · 2021: 7 · 2020: 11 · 2019: 9 · 2018: 13 · 2017: 9 · 2016: 11 · 2015: 14 · 2014: 17 · 2013: 19 · 2012: 21
- FWCI
- 7.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission (QLRT-CT-1999-00584)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- Friedreich's ataxia, mitochondria-targeted antioxidants, oxidative stress, frataxin, mitochondrial oxidative damage, MitoQ, idebenone, Trolox, vitamin E, coenzyme Q10, glutathione deficiency, fibroblasts, cell death, mitochondrial disease therapy
- MeSH terms
- Antioxidants, Fibroblasts, Friedreich Ataxia, Humans, Mitochondria, Models, Biological, Organophosphorus Compounds, Ubiquinone, Vitamin E, Benzoquinones, Drug Delivery Systems, Cell Death, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
